Belviq Cancer Risk
A randomized, double-blind, placebo-controlled clinical trial found that patients who took lorcaserin (n=462; 7.7%) were more likely to be diagnosed with cancer compared to patients who took a placebo (n=423, 7/1%). A range of different cancer types was reported by the participants, with pancreatic, colorectal, and lung cancers reported most often.
FDA is petitioning to have Belviq withdrawn because it believes that the drug’s risks outweigh any potential benefits, based on the agency’s review of the trial. Eisai Inc. has submitted a request to voluntarily withdraw Belviq, according to the FDA.
In Jan. 2020, FDA announced that it was reviewing clinical trial data and alerted the public of a potential cancer risk with Belviq based on a preliminary analysis of the data.
What is Belviq?
Belviq is a weight-loss medication that works by manipulating chemicals in the brain that control appetite. The drug is intended to be used together with a healthy diet and regular exercise to treat obesity caused by diabetes, high cholesterol, or elevated blood pressure levels. Belviq was approved by the U.S. Food & Drug Administration (FDA) on June 27, 2012.
Belviq Side Effects
Potential serious side effects of Belviq may include:
- Lung Cancer
- Colorectal Cancer
- Colon Cancer
- Pancreatic Cancer
- Breast Cancer
- Cardiovascular Events
- Heart Attack
- Heart Valve Damage
- Serotonin Syndrome
Other, less serious Belviq side effects may include:
- Allergic Reactions
- Unusual Thoughts or Behaviors
- Feelings of Extreme Happiness or Sadness
- Feelings of Standing Next to Yourself or Being Outside Your Body
- Thoughts of Suicide or Hurting Yourself
- Memory Loss
- Rapid Heart Rate
- Loss of Coordination
- Stiff Muscles
- Fast or Uneven Heart Beats
- Swelling in the Hands or Feet
- Pale Skin
- Flu Symptoms
- Sores in the Mouth or Throat
- Low Blood Sugar
- Breast Swelling or Nipple Discharge
- Penis Erection Lasting 4 Hours or More
Is Belviq Safe to Take During Pregnancy?
Belviq is classified as a Pregnancy Category X medication, which means that there is evidence of fetal abnormalities based on adverse reaction data. Belviq should only be used by pregnant women when the potential benefits of the drug are greater than its risks, according to the FDA.
If You Are Taking Belviq
If you are currently taking Belviq, you should discontinue use immediately and talk to your doctor about alternative weight-loss treatments with less severe potential side effects. Belviq is a non-flush medicine that should be disposed of at a drug take back location, according to the FDA.
Belviq Class Action Filed in New York
A New York woman who was prescribed Belviq for weight loss has filed a class action lawsuit against Eisai, Inc., alleging that the company knew about the drug’s cancer-causing potential for years, yet failed to adequately warn the public. The suit seeks damages for alleged breach of implied warranty, deceptive acts, false advertising, unjust enrichment, fraud and conversion. In addition to Eisai, the class action names as defendants Arena Pharmaceuticals Inc., which developed and licensed lorcaserin, and CVS Health Co., the pharmacy where Plaintiff purchased the drug.
Do I Have a Belviq Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Belviq lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one got cancer after taking Belviq, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.